Cell encapsulation unit) and N-acetyl-D-glucosamine (acetylated unit). It is derived from the N-deacetylation of chitin and has been used for several applications such as drug delivery, space-filling implants and in wound dressings. However, one drawback of this polymer is its weak mechanical properties and is thus often combined with other polymers such collagen to form a polymer with stronger mechanical properties for cell encapsulation applications. Agarose is a polysaccharide derived from seaweed used for nanoencapsulation of cells and the cell/agarose suspension can be modified to form microbeads by reducing the temperature during preparation. However, one drawback with the microbeads so obtained is
Industrial fermentation of glucose or other carbon sources which would encourage growth, and like primary metabolites are released into the surrounding medium without rupture of the cell membrane. In the early days of the biotechnology industry, most biopharmaceutical products were made in "E. coli"; by 2004 more biopharmaceuticals were manufactured in eukaryotic cells, like CHO cells, than in microbes, but used similar bioreactor systems. Insect cell culture systems came into use in the 2000s as well. Of primary interest among the intracellular components are microbial enzymes: catalase, amylase, protease, pectinase, glucose isomerase, cellulase, hemicellulase, lipase, lactase, streptokinase and many others. Recombinant proteins,